16. Dezember 2025
Fähzan Ahmad • 16. Dezember 2025
Why supplier trust is not GMP—and how incoming control fails audits.

Most cosmetic GMP violations originate before production starts—at raw material intake.
Manufacturers often rely on supplier COAs without verification. This is a compliance shortcut. GMP requires risk-based incoming control, not blind acceptance [ISO 22716, Clause 7]. Variability in botanical extracts, preservatives, and functional excipients is a known and documented risk.
Key failures include missing identity testing, undefined acceptance criteria, and no linkage between raw material changes and finished-product impact. When suppliers change processes, formulations may remain “the same” on paper but shift biologically or chemically.
GMP-compliant systems define:
- material criticality
- test depth per risk class
- requalification triggers
Without this, batch-to-batch drift becomes inevitable—and undocumented.
Makrolife Biotech supports GMP setups by aligning raw material risk profiles with product biology and claims, closing a gap most manufacturers ignore.
You cannot control production if you do not control inputs.








